Cargando…

Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy

OBJECTIVE: The immune inflammatory disorders rheumatoid arthritis (RA), psoriatic arthritis (PsA) and psoriasis (Ps) share common pathologic features and show responsiveness to anti-tumor necrosis factor (TNF) agents yet they are phenotypically distinct. The aim of this study was to examine if anti-...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenberg, Alexander, Fan, Hongtao, Chiu, Yahui G., Bolce, Rebecca, Tabechian, Darren, Barrett, Rick, Moorehead, Sharon, Baribaud, Frédéric, Liu, Hao, Peffer, Nancy, Shealy, David, Schwarz, Edward M., Ritchlin, Christopher T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204991/
https://www.ncbi.nlm.nih.gov/pubmed/25333715
http://dx.doi.org/10.1371/journal.pone.0110657
_version_ 1782340640708755456
author Rosenberg, Alexander
Fan, Hongtao
Chiu, Yahui G.
Bolce, Rebecca
Tabechian, Darren
Barrett, Rick
Moorehead, Sharon
Baribaud, Frédéric
Liu, Hao
Peffer, Nancy
Shealy, David
Schwarz, Edward M.
Ritchlin, Christopher T.
author_facet Rosenberg, Alexander
Fan, Hongtao
Chiu, Yahui G.
Bolce, Rebecca
Tabechian, Darren
Barrett, Rick
Moorehead, Sharon
Baribaud, Frédéric
Liu, Hao
Peffer, Nancy
Shealy, David
Schwarz, Edward M.
Ritchlin, Christopher T.
author_sort Rosenberg, Alexander
collection PubMed
description OBJECTIVE: The immune inflammatory disorders rheumatoid arthritis (RA), psoriatic arthritis (PsA) and psoriasis (Ps) share common pathologic features and show responsiveness to anti-tumor necrosis factor (TNF) agents yet they are phenotypically distinct. The aim of this study was to examine if anti-TNF therapy is associated with divergent gene expression profiles in circulating cells and target tissues of patients with these diseases. METHODS: Peripheral blood CD14(+) and CD14(−) cells were isolated from 9 RA, 12 PsA and 10 Ps patients before and after infliximab (IFX) treatment. Paired synovial (n = 3, RA, PsA) and skin biopsies (n = 5, Ps) were also collected. Gene expression was analyzed by microarrays. RESULTS: 26 out of 31 subjects responded to IFX. The transcriptional response of CD14(+) cells to IFX was unique for the three diseases, with little overlap (<25%) in significantly changed gene lists (with PsA having the largest number of changed genes). In Ps, altered gene expression was more pronounced in lesional skin (relative to paired, healthy skin) compared to blood (relative to healthy controls). Marked suppression of up-regulated genes in affected skin was noted 2 weeks after therapy but the expression patterns differed from uninvolved skin. Divergent patterns of expression were noted between the blood cells and skin or synovial tissues in individual patients. Functions that promote cell differentiation, proliferation and apoptosis in all three diseases were enriched. RA was enriched in functions in CD14(−) cells, PsA in CD14(+) cells and Ps in both CD14(+) and CD14(−) cells, however, the specific functions showed little overlap in the 3 disorders. CONCLUSION: Divergent patterns of altered gene expression are observed in RA, PsA and Ps patients in blood cells and target organs in IFX responders. Differential gene expression profiles in the blood do not correlate with those in target organs.
format Online
Article
Text
id pubmed-4204991
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42049912014-10-27 Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy Rosenberg, Alexander Fan, Hongtao Chiu, Yahui G. Bolce, Rebecca Tabechian, Darren Barrett, Rick Moorehead, Sharon Baribaud, Frédéric Liu, Hao Peffer, Nancy Shealy, David Schwarz, Edward M. Ritchlin, Christopher T. PLoS One Research Article OBJECTIVE: The immune inflammatory disorders rheumatoid arthritis (RA), psoriatic arthritis (PsA) and psoriasis (Ps) share common pathologic features and show responsiveness to anti-tumor necrosis factor (TNF) agents yet they are phenotypically distinct. The aim of this study was to examine if anti-TNF therapy is associated with divergent gene expression profiles in circulating cells and target tissues of patients with these diseases. METHODS: Peripheral blood CD14(+) and CD14(−) cells were isolated from 9 RA, 12 PsA and 10 Ps patients before and after infliximab (IFX) treatment. Paired synovial (n = 3, RA, PsA) and skin biopsies (n = 5, Ps) were also collected. Gene expression was analyzed by microarrays. RESULTS: 26 out of 31 subjects responded to IFX. The transcriptional response of CD14(+) cells to IFX was unique for the three diseases, with little overlap (<25%) in significantly changed gene lists (with PsA having the largest number of changed genes). In Ps, altered gene expression was more pronounced in lesional skin (relative to paired, healthy skin) compared to blood (relative to healthy controls). Marked suppression of up-regulated genes in affected skin was noted 2 weeks after therapy but the expression patterns differed from uninvolved skin. Divergent patterns of expression were noted between the blood cells and skin or synovial tissues in individual patients. Functions that promote cell differentiation, proliferation and apoptosis in all three diseases were enriched. RA was enriched in functions in CD14(−) cells, PsA in CD14(+) cells and Ps in both CD14(+) and CD14(−) cells, however, the specific functions showed little overlap in the 3 disorders. CONCLUSION: Divergent patterns of altered gene expression are observed in RA, PsA and Ps patients in blood cells and target organs in IFX responders. Differential gene expression profiles in the blood do not correlate with those in target organs. Public Library of Science 2014-10-21 /pmc/articles/PMC4204991/ /pubmed/25333715 http://dx.doi.org/10.1371/journal.pone.0110657 Text en © 2014 Rosenberg et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Rosenberg, Alexander
Fan, Hongtao
Chiu, Yahui G.
Bolce, Rebecca
Tabechian, Darren
Barrett, Rick
Moorehead, Sharon
Baribaud, Frédéric
Liu, Hao
Peffer, Nancy
Shealy, David
Schwarz, Edward M.
Ritchlin, Christopher T.
Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy
title Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy
title_full Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy
title_fullStr Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy
title_full_unstemmed Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy
title_short Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy
title_sort divergent gene activation in peripheral blood and tissues of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis following infliximab therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204991/
https://www.ncbi.nlm.nih.gov/pubmed/25333715
http://dx.doi.org/10.1371/journal.pone.0110657
work_keys_str_mv AT rosenbergalexander divergentgeneactivationinperipheralbloodandtissuesofpatientswithrheumatoidarthritispsoriaticarthritisandpsoriasisfollowinginfliximabtherapy
AT fanhongtao divergentgeneactivationinperipheralbloodandtissuesofpatientswithrheumatoidarthritispsoriaticarthritisandpsoriasisfollowinginfliximabtherapy
AT chiuyahuig divergentgeneactivationinperipheralbloodandtissuesofpatientswithrheumatoidarthritispsoriaticarthritisandpsoriasisfollowinginfliximabtherapy
AT bolcerebecca divergentgeneactivationinperipheralbloodandtissuesofpatientswithrheumatoidarthritispsoriaticarthritisandpsoriasisfollowinginfliximabtherapy
AT tabechiandarren divergentgeneactivationinperipheralbloodandtissuesofpatientswithrheumatoidarthritispsoriaticarthritisandpsoriasisfollowinginfliximabtherapy
AT barrettrick divergentgeneactivationinperipheralbloodandtissuesofpatientswithrheumatoidarthritispsoriaticarthritisandpsoriasisfollowinginfliximabtherapy
AT mooreheadsharon divergentgeneactivationinperipheralbloodandtissuesofpatientswithrheumatoidarthritispsoriaticarthritisandpsoriasisfollowinginfliximabtherapy
AT baribaudfrederic divergentgeneactivationinperipheralbloodandtissuesofpatientswithrheumatoidarthritispsoriaticarthritisandpsoriasisfollowinginfliximabtherapy
AT liuhao divergentgeneactivationinperipheralbloodandtissuesofpatientswithrheumatoidarthritispsoriaticarthritisandpsoriasisfollowinginfliximabtherapy
AT peffernancy divergentgeneactivationinperipheralbloodandtissuesofpatientswithrheumatoidarthritispsoriaticarthritisandpsoriasisfollowinginfliximabtherapy
AT shealydavid divergentgeneactivationinperipheralbloodandtissuesofpatientswithrheumatoidarthritispsoriaticarthritisandpsoriasisfollowinginfliximabtherapy
AT schwarzedwardm divergentgeneactivationinperipheralbloodandtissuesofpatientswithrheumatoidarthritispsoriaticarthritisandpsoriasisfollowinginfliximabtherapy
AT ritchlinchristophert divergentgeneactivationinperipheralbloodandtissuesofpatientswithrheumatoidarthritispsoriaticarthritisandpsoriasisfollowinginfliximabtherapy